The Eli Lilly, Pfizer and Sanofi-backed cancer therapy developer raised $150m despite reducing the number of shares in the IPO and floating beneath its range.
The underwriters for Praktikertjänst-backed Aprea Therapeutics have taken up the over-allotment option in full to boost proceeds to nearly $97.8m.
Panasonic, Mitsui Sumitomo and NEC all booked exits after Honda's R&D unit acquired connected driving assistant technology developer Drivemode.
Comcast NBCUniversal may have scored an exit at online women's lifestyle brand PopSugar, although the firm was reported to have sold back at least some of its shares in 2009.
The AstraZeneca-backed cancer drug developer had hoped to raise up to $212m in a US flotation but is instead pulling back due to unfavourable market conditions.
Emtek is set to sell up to $55m of its shares in online real estate platform PropertyGuru in an Australian initial public offering that could bring in up to $257m in proceeds.
AstraZeneca spinoff Viela Bio has gone public in an offering that involved existing backers buying some $70m worth of stock, and its share price has since risen 21.7%.
The Alphabet unit has already divested part of its stake in publicly-listed Uber to SoftBank at a $48bn valuation but is considering selling the rest from next month.
WarnerMedia, WPP, Discovery Communications and Scripps Networks Interactive will exit the digital media company in a cash and share acquisition.
SIG-backed online content advertiser Outbrain has been acquired for $250m in cash and a 30% stake in competitor Taboola.